Literature DB >> 7198832

Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein.

A Bakka, L Endresen, A B Johnsen, P D Edminson, H E Rugstad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7198832     DOI： 10.1016/0041-008x(81)90411-7

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  29 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Induction of drug resistance to gold sodium thiomalate in a monocyte cell line, THP-1.

Authors:  Y Ichibangase; M Yamamoto; M Yasuda; N Houki; M Nobunaga
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Metallothionein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells.

Authors:  P Farnworth; B Hillcoat; I Roos
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Cultured human cells with high levels of gold-binding cytosolic metallothionein are not resistant to the growth inhibitory effect of sodium aurothiomalate.

Authors:  A Glennås; H E Rugstad
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

5.  Protective effect of selenium on lung cancer in smelter workers.

Authors:  L Gerhardsson; D Brune; I G Nordberg; P O Wester
Journal:  Br J Ind Med       Date:  1985-09

6.  Radioresistance in cells with high content of metallothionein.

Authors:  A Bakka; A S Johnsen; L Endresen; H E Rugstad
Journal:  Experientia       Date:  1982-03-15

7.  Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer.

Authors:  K Son; L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Immunohistochemical study of metallothionein in pancreatic carcinomas.

Authors:  G Ohshio; T Imamura; N Okada; Z H Wang; K Yamaki; T Kyogoku; H Suwa; H Yamabe; M Imamura
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  Combination chemotherapy with cisplatin and nifedipine: synergistic antitumor effects against a cisplatin-resistant subline of the B16 amelanotic melanoma.

Authors:  J M Onoda; K K Nelson; S M Pilarski; N S White; R G Mihu; K V Honn
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

10.  Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells.

Authors:  P A Andrews; M P Murphy; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.